Literature DB >> 638542

Sulphinpyrazone, cardiac infarction, and the prevention of death: a successful trial or another tribulation?

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638542      PMCID: PMC1603841          DOI: 10.1136/bmj.1.6118.941-a

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  7 in total

1.  Prognosis and anticoagulant pro-phylaxis after coronary occlusion.

Authors:  J MCMICHAEL; E H PARRY
Journal:  Lancet       Date:  1960-11-05       Impact factor: 79.321

2.  An evaluation of the effect of continuous long-term anticoagulant therapy on the prognosis of myocardial infarction: a report of 82 cases.

Authors:  M M SUZMAN; H D RUSKIN; B GOLDBERG
Journal:  Circulation       Date:  1955-09       Impact factor: 29.690

Review 3.  Precordial electrocardiographic mapping. A technique to assess the efficacy of interventions designed to limit infarct size.

Authors:  J E Muller; P R Maroko; E Braunwald
Journal:  Circulation       Date:  1978-01       Impact factor: 29.690

4.  Disopyramide in myocardial infarction.

Authors: 
Journal:  Lancet       Date:  1977-12-03       Impact factor: 79.321

5.  Secondary prevention trials using clofibrate: a joint commentary on the Newcastle and Scottish trials.

Authors:  H A Dewar; M F Oliver
Journal:  Br Med J       Date:  1971-12-25

6.  Infarct size estimated from serial serum creatine phosphokinase in relation to left ventricular hemodynamics.

Authors:  W Bleifeld; D Mathey; P Hanrath; H Buss; S Effert
Journal:  Circulation       Date:  1977-02       Impact factor: 29.690

7.  Oral disopyramide for the prevention of arrhythmias in patients with acute myocardial infarction admitted to open wards.

Authors:  N Zainal; D J Carmichael; J W Griffiths; E M Besterman; P H Kidner; A D Gillham; G D Summers
Journal:  Lancet       Date:  1977-10-29       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.